🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Appropriateness of Hemostatic Agent Use in Cardiovascular Surgery (HAEMOVAX)

Recruitingn/aAges 18 Years - anyAllUniversity of Milan
NCT07699016 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Hemostatic agents are widely used in cardiac and vascular surgery to support intraoperative bleeding control. Despite their clinical relevance and substantial economic impact, little is known about real-world patterns of use, adherence to evidence-based recommendations, and the alignment between clinicians' perceived knowledge and actual decision-making. HAEMOVAX is a single-center mixed-methods observational study conducted at IRCCS Galeazzi-Sant'Ambrogio Hospital, Milan, Italy. The study combines an anonymous survey of cardiovascular surgeons with a retrospective audit of institutional hemostatic agent consumption. The primary objective is to evaluate the appropriateness of hemostatic agent selection using a Knowledge-Practice Alignment Score (KPA-Score) derived from standardized clinical vignettes based on current EACTS and ESA recommendations. Secondary objectives include assessment

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Physicians with a surgical role in the Departments of Cardiac Surgery or Vascular Surgery at IRCCS Galeazzi-Sant'Ambrogio, Milan Including attending surgeons, consultant surgeons, and surgical residents * Active participation in cardiovascular operative procedures during the study period (or within the preceding 12 months) * Employment at the study institution at the time of survey administration Willingness to participate and complete the anonymous structured questionnaire Exclusion Criteria: * Non-surgical healthcare personnel (e.g., nurses, anesthesiologists, administrative staff, or allied health professionals) * Surgeons not involved in operative cardiovascular practice during the study period * External collaborators or visiting surgeons without regular clinical activity at the institution * Individuals who do not provide informed consent for participation in the anonymous survey * Questionnaires with missing or incomplete vignette responses preventing calculation of the KPA-Score
💊

What it tests

  • observational study
📍

Where

1 site
IRCCS Galeazzi Sant'Ambrogio Hospital
Milan, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy